| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
1,220,000,000 |
| Market
Cap: |
19.26(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$7.26 - $16.13 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 1153 |
| Guru Rank Value : 0 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Viatris is a global healthcare company. Co.'s portfolio comprises more than 1,400 approved molecules across a range of key therapeutic areas. Co. has four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. Key products sold by the Developed Markets segment include Lyrica®, Lipitor®, Creon®, Influvac®, Wixela™ Inhub™, and the EpiPen® Auto-Injector. Key products within the Greater China segment include Lipitor®, Norvasc®, and Viagra®. Key products within the JANZ segment include AMITIZA®, Lipacreon®, Lyrica®, Norvasc®, and Effexor®. Among Co.'s products sold in the Emerging Markets segment are Lipitor®, Lyrica®, Norvasc®, Celebrex®, and anti-retrovirals.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
82,000 |
82,000 |
| Total Buy Value |
$0 |
$0 |
$756,002 |
$756,002 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
2 |
2 |
| Total Shares Sold |
0 |
7,032 |
7,032 |
1,397,221 |
| Total Sell Value |
$0 |
$72,045 |
$72,045 |
$15,935,452 |
| Total People Sold |
0 |
1 |
1 |
8 |
| Total Sell Transactions |
0 |
1 |
1 |
18 |
| End Date |
2025-11-13 |
2025-08-12 |
2025-02-11 |
2024-02-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mistras Theodora |
Chief Financial Officer |
• • – |
2026-01-01 |
4 |
D |
$12.45 |
$181,745 |
D/D |
(14,598) |
35,842 |
|
- |
|
| Mistras Theodora |
Chief Financial Officer |
• • – |
2026-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,260 |
37,045 |
|
- |
|
| Le Goff Corinne |
Chief Commercial Officer |
• • – |
2025-09-11 |
4 |
AS |
$10.25 |
$72,045 |
D/D |
(7,032) |
35,299 |
|
28% |
|
| Enrietti Andrew |
See Remarks |
• – – |
2025-08-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
130,000 |
|
13% |
|
| Smith Scott Andrew |
Chief Executive Officer |
• • – |
2025-08-12 |
4 |
B |
$9.99 |
$219,740 |
D/D |
22,000 |
314,807 |
0.01 |
18% |
|
| Smith Scott Andrew |
Chief Executive Officer |
• • – |
2025-05-12 |
4 |
B |
$8.94 |
$536,262 |
D/D |
60,000 |
292,807 |
0.01 |
10% |
|
| Le Goff Corinne |
Chief Commercial Officer |
• – – |
2025-04-15 |
4 |
D |
$7.48 |
$148,687 |
D/D |
(19,878) |
42,331 |
|
- |
|
| Le Goff Corinne |
Chief Commercial Officer |
• – – |
2025-04-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
41,112 |
43,186 |
|
- |
|
| Smith Scott Andrew |
Chief Executive Officer |
• • – |
2025-03-04 |
4 |
D |
$9.37 |
$355,554 |
D/D |
(37,946) |
232,807 |
|
- |
|
| Smith Scott Andrew |
Chief Executive Officer |
• • – |
2025-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
96,431 |
234,353 |
|
- |
|
| Korman Harry |
|
– • – |
2025-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,977 |
113,937 |
|
- |
|
| Cornwell W Don |
|
– • – |
2025-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,977 |
80,342 |
|
- |
|
| Lyons Dillon Joellen |
|
– • – |
2025-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,977 |
77,691 |
|
- |
|
| Kilts James M |
|
– • – |
2025-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,977 |
136,422 |
|
- |
|
| Roman Brian |
Chief Legal Officer |
• – – |
2025-03-04 |
4 |
D |
$9.37 |
$846,355 |
D/D |
(90,326) |
193,916 |
|
- |
|
| Roman Brian |
Chief Legal Officer |
• – – |
2025-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
206,263 |
265,061 |
|
- |
|
| Parrish Mark W |
|
– • – |
2025-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,977 |
140,395 |
|
- |
|
| Vivaldi Coelho Rogerio |
|
– • – |
2025-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,691 |
21,691 |
|
- |
|
| Mark Richard A |
|
– • – |
2025-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,977 |
91,310 |
|
- |
|
| Le Goff Corinne |
Chief Commercial Officer |
• – – |
2025-03-04 |
4 |
D |
$9.37 |
$157,388 |
D/D |
(16,797) |
21,097 |
|
- |
|
| Le Goff Corinne |
Chief Commercial Officer |
• – – |
2025-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
37,894 |
21,618 |
|
- |
|
| Finney Elisha W |
|
– • – |
2025-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,977 |
37,832 |
|
- |
|
| Higgins Melina E |
|
– • – |
2025-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,977 |
121,213 |
|
- |
|
| Mistras Theodora |
Chief Financial Officer |
• – – |
2025-03-04 |
4 |
D |
$9.37 |
$168,266 |
D/D |
(17,958) |
25,180 |
|
- |
|
| Mistras Theodora |
Chief Financial Officer |
• – – |
2025-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
32,472 |
25,912 |
|
- |
|
283 Records found
|
|
Page 1 of 12 |
|
|
0.34 (2.11%) 
